Lazard Asset Management LLC Pulmonx Corp Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 9,996 shares of LUNG stock, worth $89,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,996
Previous 9,732
2.71%
Holding current value
$89,564
Previous $80,000
16.25%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$49.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$27.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$20.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$13.8 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $334M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...